On April 24, 2026, Merck revealed its collaboration with Google Cloud, aiming to enhance its drug discovery and development processes through advanced AI tools.
This partnership underscores a growing trend of technology firms aligning with pharmaceutical companies to leverage cutting-edge innovations.
The deal, which could be valued at up to $1 billion, highlights the increasing importance of AI in the healthcare sector.